Search results
Earnings call: Amneal Pharmaceuticals sees robust growth in Q1 2024 By Investing.com
Investing.com· 7 days agoThis growth was fueled by double-digit increases across all segments—Generics, Specialty, and...
This growth was fueled by double-digit increases across all segments—Generics, Specialty, and...